Skip to main content

Table 6 Final sample respondents’ profile

From: Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study

 

UK

Denmark

Sweden

N = 1777a

N = 1799a

N = 484b

Male (%)

50

50

63

Age, years (mean)

43.5 (14.5)

45.5 (15.8)

63.8 (9.2)

BMI kg/m2 (mean)

26.1 (5.7)

26.2 (5.4)

30.1 (5.3)

Treatment with oral anti-diabetic drugs (%)

-

-

87 %

Insulin treatment (%)

-

-

34 %

Diabetes duration, years (mean)

-

-

9.5 (7.0)

Duration of insulin treatment (mean years)

-

-

7.5 (6.6)

Currently employed (%)

59

52

31

  1. aSample of the general population bAdults with Type 2 diabetes